ProfileGDS4132 / 214998_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 35% 33% 43% 40% 35% 41% 42% 53% 44% 39% 47% 38% 35% 38% 42% 38% 40% 42% 40% 36% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10187.780235
GSM201543Muscle PCOS pioglitazone 12173.985633
GSM201544Muscle PCOS pioglitazone 161114.11543
GSM201545Muscle PCOS pioglitazone 201110.56640
GSM201829Muscle PCOS pioglitazone 23194.979735
GSM201830Muscle PCOS pioglitazon 251110.16441
GSM201831Muscle PCOS pioglitazone 271109.82642
GSM201832Muscle PCOS pioglitazone 31139.65953
GSM201833Muscle PCOS pioglitazone 41108.37144
GSM201834Muscle PCOS pioglitazone 8199.147739
GSM201835Muscle PCOS after pioglitazone 102110.28947
GSM201836Muscle PCOS after pioglitazone 12286.45138
GSM201837Muscle PCOS after pioglitazone 16275.047635
GSM201838Muscle PCOS after pioglitazone 20287.496938
GSM201839Muscle PCOS after pioglitazone 232101.36442
GSM201840Muscle PCOS after pioglitazone 25294.862738
GSM201841Muscle PCOS after pioglitazone 27286.939540
GSM201842Muscle PCOS after pioglitazone 3288.971442
GSM201843Muscle PCOS after pioglitazone 4298.6540
GSM201844Muscle PCOS after pioglitazone 8287.407236